CYP2R1

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, CYP2R1 mutation is significantly associated with the drug of many other genes, with 24 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible CYP2R1-associated genes across cancer lineages are Zoledronate, Dactinomycin, and 123829. Each is linked with CYP2R1 in more than 1 cancer types. Because this analysis shows association rather than direction, both CYP2R1-to-partner and partner-to-CYP2R1 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CYP2R1→partner) and Y-score (partner→CYP2R1) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINEZoledronate →+0.315+2.649.024.04631
LARGE_INTESTINEDactinomycin →+0.645+2.649.005.04631
LARGE_INTESTINE123829 →+0.595+2.649.041.04631
LARGE_INTESTINE50869 →+0.425+2.649.045.04631
LARGE_INTESTINEOF-1 →+0.322+2.646.025.04731
LARGE_INTESTINESavolitinib →+0.407+2.777.022.03831
Each partner links to its Q-omics profile. Showing the 6 strongest of 24 associations by consensus.

Exploration